chr8-130780466-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001115.3(ADCY8):c.3680G>A(p.Arg1227Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,680 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
ADCY8
NM_001115.3 missense
NM_001115.3 missense
Scores
2
9
8
Clinical Significance
Conservation
PhyloP100: 7.40
Genes affected
ADCY8 (HGNC:239): (adenylate cyclase 8) Adenylate cyclase is a membrane bound enzyme that catalyses the formation of cyclic AMP from ATP. The enzymatic activity is under the control of several hormones, and different polypeptides participate in the transduction of the signal from the receptor to the catalytic moiety. Stimulatory or inhibitory receptors (Rs and Ri) interact with G proteins (Gs and Gi) that exhibit GTPase activity and they modulate the activity of the catalytic subunit of the adenylyl cyclase [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADCY8 | NM_001115.3 | c.3680G>A | p.Arg1227Gln | missense_variant | 18/18 | ENST00000286355.10 | |
ADCY8 | XM_005250769.4 | c.3590G>A | p.Arg1197Gln | missense_variant | 17/17 | ||
ADCY8 | XM_006716501.4 | c.3482G>A | p.Arg1161Gln | missense_variant | 17/17 | ||
ADCY8 | XM_017013006.2 | c.3392G>A | p.Arg1131Gln | missense_variant | 16/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADCY8 | ENST00000286355.10 | c.3680G>A | p.Arg1227Gln | missense_variant | 18/18 | 1 | NM_001115.3 | P1 | |
ADCY8 | ENST00000377928.7 | c.3287G>A | p.Arg1096Gln | missense_variant | 15/15 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151854Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
151854
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251188Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135736
GnomAD3 exomes
AF:
AC:
6
AN:
251188
Hom.:
AF XY:
AC XY:
4
AN XY:
135736
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461826Hom.: 0 Cov.: 35 AF XY: 0.0000124 AC XY: 9AN XY: 727216
GnomAD4 exome
AF:
AC:
23
AN:
1461826
Hom.:
Cov.:
35
AF XY:
AC XY:
9
AN XY:
727216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151854Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74100
GnomAD4 genome
AF:
AC:
6
AN:
151854
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74100
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | The c.3680G>A (p.R1227Q) alteration is located in exon 18 (coding exon 18) of the ADCY8 gene. This alteration results from a G to A substitution at nucleotide position 3680, causing the arginine (R) at amino acid position 1227 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Uncertain
D;T
Sift4G
Benign
T;T
Polyphen
D;B
Vest4
MutPred
Loss of solvent accessibility (P = 0.0155);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at